Metabolism of benzo(e)pyrene by rat liver microsomal enzymes. 1980

M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
Biology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA.

Metabolites of benzo(e)pyrene (B[e]P) formed upon incubation of [3H]-B[e]P with hepatic microsomes from control and induced rats have been separated by high-pressure liquid chromatography and identified by comparison of retention times, absorbance and fluorescence spectra with those of synthetic standards. The major metabolite produced was B[e]P-4,5-dihydrodiol, accounting for 20-30% of the total metabolism depending on the source of the microsomes. This was followed by a phenolic metabolite (shown not to be 4-OH-; 9-OH-; or 10-OH-B[e]P). A possible proximate carcinogenic derivative of B[e]P, B[e]P-9,10-dihydrodiol, was identified, but was found to constitute less than 1% of the total metabolites. Similar results were obtained with a purified and reconstituted mixed-function oxidase system. In these later incubations, production of the dihydrodiols was dependent on the addition of purified epoxide hydrase to the incubation mixtures. These results suggest that formation of the reactive diol-epoxide, 9,10-dihydroxy-11,12-epoxy-9,10,11,-12-tetrahydro-B[e]P, a potential ultimate carcinogenic metabolite of B[e]P, is not favored by rat liver enzymes. This provides a partial explanation for the lack of carcinogenicity of B[e]P within the framework of the bay region theory of chemical carcinogenesis.

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004851 Epoxide Hydrolases Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively. Epoxide Hydrase,Epoxide Hydrases,Epoxide Hydratase,Epoxide Hydratases,Epoxide Hydrolase,9,10-Epoxypalmitic Acid Hydrase,Microsomal Epoxide Hydrolase,Styrene Epoxide Hydrolase,9,10 Epoxypalmitic Acid Hydrase,Acid Hydrase, 9,10-Epoxypalmitic,Epoxide Hydrolase, Microsomal,Epoxide Hydrolase, Styrene,Hydrase, 9,10-Epoxypalmitic Acid,Hydrase, Epoxide,Hydrases, Epoxide,Hydratase, Epoxide,Hydratases, Epoxide,Hydrolase, Epoxide,Hydrolase, Microsomal Epoxide,Hydrolase, Styrene Epoxide,Hydrolases, Epoxide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001564 Benzo(a)pyrene A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke. 3,4-Benzopyrene,3,4-Benzpyrene,3,4 Benzopyrene,3,4 Benzpyrene
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D020318 Rats, Long-Evans An outbred strain of rats developed in 1915 by crossing several Wistar Institute white females with a wild gray male. Inbred strains have been derived from this original outbred strain, including Long-Evans cinnamon rats (RATS, INBRED LEC) and Otsuka-Long-Evans-Tokushima Fatty rats (RATS, INBRED OLETF), which are models for Wilson's disease and non-insulin dependent diabetes mellitus, respectively. Long-Evans Rat,Long Evans Rats,Evans Rats, Long,Long Evans Rat,Long-Evans Rats,Rat, Long-Evans,Rats, Long Evans

Related Publications

M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
November 1981, Archives of biochemistry and biophysics,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
August 1976, The Journal of biological chemistry,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
January 1977, Cancer research,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
October 1986, Cancer research,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
August 1970, Biochemical pharmacology,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
May 1983, Molecular pharmacology,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
October 1980, Chemico-biological interactions,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
April 1967, Biochemical pharmacology,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
April 1981, Biochemical pharmacology,
M C MacLeod, and W Levin, and A H Conney, and R E Lehr, and B K Mansfield, and D M Jerina, and J K Selkirk
December 1977, Life sciences,
Copied contents to your clipboard!